TY - JOUR
T1 - Polytonic Drug Release via Multi-Hierarchical Microstructures Enabled by Nano-Metamaterials
AU - Lou, Qi
AU - Feng, Feng
AU - Hui, Junfeng
AU - Zhang, Peisen
AU - Qin, Shijie
AU - Ouyang, Xiaoping
AU - Wu, Dazhuan
AU - Wang, Xiuyu
N1 - Publisher Copyright:
© 2023 Wiley-VCH GmbH.
PY - 2023/6/13
Y1 - 2023/6/13
N2 - ″Nano-metamaterials″, rationally designed novel class metamaterials with multilevel microarchitectures and both characteristic sizes and whole sizes at the nanoscale, are introduced into the area of drug delivery system (DDS), and the relationship between release profile and treatment efficacy at the single-cell level is revealed for the first time. Fe3+-core-shell-corona nano-metamaterials (Fe3+-CSCs) are synthesized using a dual-kinetic control strategy. The hierarchical structure of Fe3+-CSCs, with a homogeneous interior core, an onion-like shell, and a hierarchically porous corona. A novel polytonic drug release profile occurred, which consists of three sequential stages: burst release, metronomic release, and sustained release. The Fe3+-CSCs results in overwhelming accumulation of lipid reactive oxygen species (ROS), cytoplasm ROS, and mitochondrial ROS in tumor cells and induces unregulated cell death. This cell death modality causes cell membranes to form blebs, seriously corrupting cell membranes to significantly overcome the drug-resistance issues. It is first demonstrated that nano-metamaterials of well-defined microstructures can modulate drug release profile at the single cell level, which in turn alters the downstream biochemical reactions and subsequent cell death modalities. This concept has significant implications in the drug delivery area and can serve to assist in designing potential intelligent nanostructures for novel molecular-based diagnostics and therapeutics.
AB - ″Nano-metamaterials″, rationally designed novel class metamaterials with multilevel microarchitectures and both characteristic sizes and whole sizes at the nanoscale, are introduced into the area of drug delivery system (DDS), and the relationship between release profile and treatment efficacy at the single-cell level is revealed for the first time. Fe3+-core-shell-corona nano-metamaterials (Fe3+-CSCs) are synthesized using a dual-kinetic control strategy. The hierarchical structure of Fe3+-CSCs, with a homogeneous interior core, an onion-like shell, and a hierarchically porous corona. A novel polytonic drug release profile occurred, which consists of three sequential stages: burst release, metronomic release, and sustained release. The Fe3+-CSCs results in overwhelming accumulation of lipid reactive oxygen species (ROS), cytoplasm ROS, and mitochondrial ROS in tumor cells and induces unregulated cell death. This cell death modality causes cell membranes to form blebs, seriously corrupting cell membranes to significantly overcome the drug-resistance issues. It is first demonstrated that nano-metamaterials of well-defined microstructures can modulate drug release profile at the single cell level, which in turn alters the downstream biochemical reactions and subsequent cell death modalities. This concept has significant implications in the drug delivery area and can serve to assist in designing potential intelligent nanostructures for novel molecular-based diagnostics and therapeutics.
KW - ROS
KW - cell death modalities
KW - drug release profiles
KW - drug resistance
KW - ferroptosis
KW - hierarchical structures
KW - nano-metamaterials
UR - https://www.scopus.com/pages/publications/85150791852
U2 - 10.1002/adhm.202202826
DO - 10.1002/adhm.202202826
M3 - 文章
C2 - 36871175
AN - SCOPUS:85150791852
SN - 2192-2640
VL - 12
JO - Advanced Healthcare Materials
JF - Advanced Healthcare Materials
IS - 15
M1 - 2202826
ER -